| Business Summary | | Spire
Corporation
is
organized
into
two
separate
businesses,
solar
energy
and
biotechnology
surface
engineering.
On
October
25,
2000,
the
Company
formed
a
wholly
owned
subsidiary
for
the
placement
of
its
assets
from
its
biotechnology
surface
engineering
division.
This
subsidiary,
Spire
Biomedical,
Inc.,
has
been
formed
to
pursue
its
own
business
objectives,
which
may
include
the
possibility
of
seeking
outside
investment.
Spire's
solar
energy
business
is
directed
toward
the
production
of
solar
electric
systems
for
use
in
distributed
power
generation.
Spire
is
engaged
in
the
design
and
manufacture
of
specialized
equipment
for
the
production
of
terrestrial
PV
solar
electric
modules
from
solar
cells.
Spire
provides
solar
electric
systems
through
its
Chicago
operations. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SPIR
is
engaged
in
two
separate
businesses,
solar
energy
and
biotechnology
surface
engineering.
In
2000,
the
Company
formed
a
new
subsidiary,
Spire
Biomedical,
Inc.,
which
will
pursue
its
own
objectives.
For
the
three
months
ended
3/31/01,
revenues
fell
29%
to
$3.2
million.
Net
loss
totaled
$603
thousand
vs.
an
income
of
$267
thousand.
Revenues
reflect
lower
systems
sales
in
Chicago.
Net
loss
reflects
increased
cost
of
goods
sold
as
a
percentage
of
revenues. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
2,964;
after
tax
earnings
were
-697. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Roger Little, 60 Chairman,
Pres and CEO | $199K | -- | Richard Gregorio, 45 CFO,
VP, Treasurer, Chief Accounting Officer and Clerk | 128K | $57K | Stephen Hogan, 48 Exec.
VP and Gen. Mang., Spire Solar | 132K | -- | Mark Little, 39 VP
and Gen. Mang., Spire Biomedical | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|